Acrokeratosis paraneoplastica: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
Acrokeratosis paraneoplastica is a rare obligate paraneoplastic dermatosis characterized by erythematosquamous lesions localized symmetrically at the acral sites. Acrokeratosis paraneoplastica of Bazex is a cutaneous condition characterized by psoriasiform changes | Acrokeratosis paraneoplastica is a rare obligate [[paraneoplastic]] [[dermatosis]] characterized by erythematosquamous lesions localized symmetrically at the acral sites. Acrokeratosis paraneoplastica of Bazex is a cutaneous condition characterized by psoriasiform changes in the hands, feet, ears, and nose, with involvement of the nails and the periungual tissues being characteristic and indistinguishable from [[psoriatic nails]]. The condition is associated with [[carcinoma]]s of the upper aerodigestive tract.<ref name="Fitz2">Freedberg, et al. (2003). ''Fitzpatrick's Dermatology in General Medicine''. (6th ed.). McGraw-Hill. ISBN 0-07-138076-0.</ref> | ||
==Pathophysiology== | ==Pathophysiology== | ||
Although the exact mechanism is unclear, several hypothesis<ref name="Pecora1983">{{cite journal|last1=Pecora|first1=A. L.|title=Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature|journal=Archives of Dermatology|volume=119|issue=10|year=1983|pages=820–826|issn=0003987X|doi=10.1001/archderm.119.10.820}}</ref><ref name="LuckerSteijlen1995">{{cite journal|last1=Lucker|first1=G.P.H.|last2=Steijlen|first2=P.M.|title=Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin's disease|journal=British Journal of Dermatology|volume=133|issue=2|year=1995|pages=322–325|issn=0007-0963|doi=10.1111/j.1365-2133.1995.tb02641.x}}</ref><ref name="SarkarKnecht1998">{{cite journal|last1=Sarkar|first1=B.|last2=Knecht|first2=R.|last3=Sarkar|first3=C.|last4=Weidauer|first4=H.|title=Bazex syndrome (acrokeratosis paraneoplastica)|journal=European Archives of Oto-Rhino Laryngology|volume=255|issue=4|year=1998|pages=205–210|issn=0937-4477|doi=10.1007/s004050050044}}</ref><ref name="Jacobsen1984">{{cite journal|last1=Jacobsen|first1=F. K.|title=Acrokeratosis paraneoplastica (Bazex' syndrome)|journal=Archives of Dermatology|volume=120|issue=4|year=1984|pages=502–504|issn=0003987X|doi=10.1001/archderm.120.4.502}}</ref> | Although the exact mechanism is unclear, several hypothesis have been suggested such as: | ||
*Immunologic mechanisms in which [[antibodies]] directed against the tumour cross-react with antigens in the [[epidermis]] or[[ basement membrane]] | |||
*Tumour’s capability to secrete growth factors like TGF-alpha that affects epidermal growth and epithelial differentiation | |||
*Genetic susceptibility due to the occurrence of the same [[HLA]] types (A3 and B8) in many cases of the disease<ref name="Pecora1983">{{cite journal|last1=Pecora|first1=A. L.|title=Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature|journal=Archives of Dermatology|volume=119|issue=10|year=1983|pages=820–826|issn=0003987X|doi=10.1001/archderm.119.10.820}}</ref><ref name="LuckerSteijlen1995">{{cite journal|last1=Lucker|first1=G.P.H.|last2=Steijlen|first2=P.M.|title=Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin's disease|journal=British Journal of Dermatology|volume=133|issue=2|year=1995|pages=322–325|issn=0007-0963|doi=10.1111/j.1365-2133.1995.tb02641.x}}</ref><ref name="SarkarKnecht1998">{{cite journal|last1=Sarkar|first1=B.|last2=Knecht|first2=R.|last3=Sarkar|first3=C.|last4=Weidauer|first4=H.|title=Bazex syndrome (acrokeratosis paraneoplastica)|journal=European Archives of Oto-Rhino Laryngology|volume=255|issue=4|year=1998|pages=205–210|issn=0937-4477|doi=10.1007/s004050050044}}</ref><ref name="Jacobsen1984">{{cite journal|last1=Jacobsen|first1=F. K.|title=Acrokeratosis paraneoplastica (Bazex' syndrome)|journal=Archives of Dermatology|volume=120|issue=4|year=1984|pages=502–504|issn=0003987X|doi=10.1001/archderm.120.4.502}}</ref> | |||
==Causes== | ==Causes== | ||
| Line 27: | Line 27: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Bazex syndrome has been reported almost exclusively in men over the age of 40 years and has unanimously been associated with malignancies. There are nearly 140 published cases of Bazex Syndrome.<ref name="PoligoneChristensen2007">{{cite journal|last1=Poligone|first1=Brian|last2=Christensen|first2=Sean R|last3=Lazova|first3=Rossitza|last4=Heald|first4=Peter W|title=Bazex syndrome (acrokeratosis paraneoplastica)|journal=The Lancet|volume=369|issue=9560|year=2007|pages=530|issn=01406736|doi=10.1016/S0140-6736(07)60240-2}}</ref><ref name="MooreDevere2008">{{cite journal|last1=Moore|first1=Rachael L.|last2=Devere|first2=Theresa S.|title=Epidermal Manifestations of Internal Malignancy|journal=Dermatologic Clinics|volume=26|issue=1|year=2008|pages=17–29|issn=07338635|doi=10.1016/j.det.2007.08.008}}</ref> | * Bazex syndrome has been reported almost exclusively in men over the age of 40 years and has unanimously been associated with [[malignancies]]. | ||
* There are nearly 140 published cases of Bazex Syndrome.<ref name="PoligoneChristensen2007">{{cite journal|last1=Poligone|first1=Brian|last2=Christensen|first2=Sean R|last3=Lazova|first3=Rossitza|last4=Heald|first4=Peter W|title=Bazex syndrome (acrokeratosis paraneoplastica)|journal=The Lancet|volume=369|issue=9560|year=2007|pages=530|issn=01406736|doi=10.1016/S0140-6736(07)60240-2}}</ref><ref name="MooreDevere2008">{{cite journal|last1=Moore|first1=Rachael L.|last2=Devere|first2=Theresa S.|title=Epidermal Manifestations of Internal Malignancy|journal=Dermatologic Clinics|volume=26|issue=1|year=2008|pages=17–29|issn=07338635|doi=10.1016/j.det.2007.08.008}}</ref> | |||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
Bazex syndrome is most frequently associated with squamous cell carcinoma (SCC) of the head and neck, particularly of the oral cavity, oropharynx, larynx and esophagus. Association with other malignant tumours including cutaneous squamous cell carcinoma, transitional cell carcinoma of the bladder, metastatic thymic carcinoma, ductal carcinoma of the breast, adenocarcinomas of the colon and prostate, | * Bazex syndrome is most frequently associated with [[squamous cell carcinoma]] (SCC) of the head and neck, particularly of the oral cavity, [[oropharynx]], [[larynx]] and [[esophagus]]. Association with other malignant tumours including cutaneous squamous cell carcinoma, [[transitional cell carcinoma|transitional cell carcinoma of the bladder]], metastatic [[thymic carcinoma]], [[ductal carcinoma of the breast]], [[adenocarcinomas]] of the colon and prostate, [[liposarcoma]]s, [[Hodgkin’s disease]], peripheral [[T-cell lymphoma]], metastatic neuroendocrine tumour, bronchial [[carcinoid]] tumour and tumours of the liver, stomach, thymus, uterus, vulva, genitourinary tract and bone marrow are rarely reported. | ||
* Remarkably, 50% of the reported malignancies have metastasis to the [[cervical lymph nodes]]; on the other hand, approximately 16% of the cervical lymph nodes metastasis associated with Bazex syndrome have unknown primary tumour.<ref name="MooreDevere2008">{{cite journal|last1=Moore|first1=Rachael L.|last2=Devere|first2=Theresa S.|title=Epidermal Manifestations of Internal Malignancy|journal=Dermatologic Clinics|volume=26|issue=1|year=2008|pages=17–29|issn=07338635|doi=10.1016/j.det.2007.08.008}}</ref><ref name="ChaveBamford2004">{{cite journal|last1=Chave|first1=T. A.|last2=Bamford|first2=W. M.|last3=Harman|first3=K.E.|title=Acrokeratosis paraneoplastica associated with recurrent metastatic thymic carcinoma|journal=Clinical and Experimental Dermatology|volume=29|issue=4|year=2004|pages=430–432|issn=0307-6938|doi=10.1111/j.1365-2230.2004.01539.x}}</ref><ref name="SatorBreier2006">{{cite journal|last1=Sator|first1=Paul-Gunther|last2=Breier|first2=Friedrich|last3=Gschnait|first3=Friedrich|title=Acrokeratosis paraneoplastica (Bazex's syndrome): Association with liposarcoma|journal=Journal of the American Academy of Dermatology|volume=55|issue=6|year=2006|pages=1103–1105|issn=01909622|doi=10.1016/j.jaad.2006.05.064}}</ref> | |||
==Diagnosis== | ==Diagnosis== | ||
===History and Symptoms=== | ===History and Symptoms=== | ||
In the majority of the reported cases, cutaneous lesions precede the diagnosis of malignancy by several months. | In the majority of the reported cases, cutaneous lesions precede the diagnosis of [[malignancy]] by several months. | ||
===Physical Examination=== | ===Physical Examination=== | ||
The main features of this paraneoplasia is the presence of symmetrical papulosquamous eruptions (psoriasiform cutaneous eruptions), nail dystrophy and skin scaling usually localized in the body extremities (acral distribution) which may affect ears, nose, cheeks, hands, feet, fingers, toes, elbows and knees. Less frequently, skin bullae and vesicles as well as mucosa alterations can occur concomitantly to the more typical cutaneous lesions. | * The main features of this paraneoplasia is the presence of symmetrical papulosquamous eruptions ([[psoriasiform]] cutaneous eruptions), [[nail dystrophy]] and [[skin scaling]] usually localized in the body extremities (acral distribution) which may affect ears, nose, cheeks, hands, feet, fingers, toes, elbows and knees. | ||
* Less frequently, skin [[bullae]] and [[vesicles]] as well as [[mucosa]] alterations can occur concomitantly to the more typical cutaneous lesions. | |||
===Laboratory Findings=== | ===Laboratory Findings=== | ||
Any clinical sign that could suggest Bazex syndrome should automatically guide a cutaneous biopsy. Skin biopsies generally provide a mixture of findings that may be found in several more common disorders like hyperkeratosis, acanthosis, spongiosis, mononuclear perivascular infiltrate, dyskeratotic keratinocytes and vacuolar degeneration of keratinocytes. | * Any clinical sign that could suggest Bazex syndrome should automatically guide a cutaneous biopsy. | ||
* [[Skin biopsies]] generally provide a mixture of findings that may be found in several more common disorders like [[hyperkeratosis]], [[acanthosis]], [[spongiosis]], mononuclear perivascular infiltrate, dyskeratotic [[keratinocytes]] and vacuolar degeneration of keratinocytes. | |||
===Other Diagnostic Tests=== | ===Other Diagnostic Tests=== | ||
A complete screening of the upper aerodigestive tract should be done. If no tumour is found in the head and neck region, further investigation of other possible affected primary sites or metastasis should be performed, such as mediastinum, colon, bladder, prostate, uterus and vulva. Rarely direct immunofluorescence has been positive in patients with Bazex syndrome.<ref name="Pecora1983">{{cite journal|last1=Pecora|first1=A. L.|title=Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature|journal=Archives of Dermatology|volume=119|issue=10|year=1983|pages=820–826|issn=0003987X|doi=10.1001/archderm.119.10.820}}</ref> | * A complete screening of the upper aerodigestive tract should be done. | ||
* If no tumour is found in the head and neck region, further investigation of other possible affected primary sites or metastasis should be performed, such as mediastinum, colon, bladder, prostate, uterus and vulva. | |||
* Rarely [[direct immunofluorescence]] has been positive in patients with Bazex syndrome.<ref name="Pecora1983">{{cite journal|last1=Pecora|first1=A. L.|title=Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature|journal=Archives of Dermatology|volume=119|issue=10|year=1983|pages=820–826|issn=0003987X|doi=10.1001/archderm.119.10.820}}</ref> | |||
==Treatment== | ==Treatment== | ||
The definitive therapy is the treatment of the underlying tumour. Skin lesions associated with Bazex syndrome seems to be resistant to several therapeutical modalities such as keratolytics, steroids and antibiotics and the nail changes are usually persistent. | * The definitive therapy is the treatment of the underlying tumour. | ||
* Skin lesions associated with Bazex syndrome seems to be resistant to several therapeutical modalities such as keratolytics, steroids and antibiotics and the nail changes are usually persistent. | |||
==References== | ==References== | ||
Latest revision as of 14:17, 30 July 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mugilan Poongkunran M.B.B.S [2]
Synonyms and keywords: Bazex syndrome, Acrokeratosis neoplastica
Overview
Acrokeratosis paraneoplastica is a rare obligate paraneoplastic dermatosis characterized by erythematosquamous lesions localized symmetrically at the acral sites. Acrokeratosis paraneoplastica of Bazex is a cutaneous condition characterized by psoriasiform changes in the hands, feet, ears, and nose, with involvement of the nails and the periungual tissues being characteristic and indistinguishable from psoriatic nails. The condition is associated with carcinomas of the upper aerodigestive tract.[1]
Pathophysiology
Although the exact mechanism is unclear, several hypothesis have been suggested such as:
- Immunologic mechanisms in which antibodies directed against the tumour cross-react with antigens in the epidermis orbasement membrane
- Tumour’s capability to secrete growth factors like TGF-alpha that affects epidermal growth and epithelial differentiation
- Genetic susceptibility due to the occurrence of the same HLA types (A3 and B8) in many cases of the disease[2][3][4][5]
Causes
The etiology of Bazex syndrome is still unknown.
Differentiating Acrokeratosis Paraneoplastica from Other Diseases
Epidemiology and Demographics
- Bazex syndrome has been reported almost exclusively in men over the age of 40 years and has unanimously been associated with malignancies.
- There are nearly 140 published cases of Bazex Syndrome.[6][7]
Natural History, Complications and Prognosis
- Bazex syndrome is most frequently associated with squamous cell carcinoma (SCC) of the head and neck, particularly of the oral cavity, oropharynx, larynx and esophagus. Association with other malignant tumours including cutaneous squamous cell carcinoma, transitional cell carcinoma of the bladder, metastatic thymic carcinoma, ductal carcinoma of the breast, adenocarcinomas of the colon and prostate, liposarcomas, Hodgkin’s disease, peripheral T-cell lymphoma, metastatic neuroendocrine tumour, bronchial carcinoid tumour and tumours of the liver, stomach, thymus, uterus, vulva, genitourinary tract and bone marrow are rarely reported.
- Remarkably, 50% of the reported malignancies have metastasis to the cervical lymph nodes; on the other hand, approximately 16% of the cervical lymph nodes metastasis associated with Bazex syndrome have unknown primary tumour.[7][8][9]
Diagnosis
History and Symptoms
In the majority of the reported cases, cutaneous lesions precede the diagnosis of malignancy by several months.
Physical Examination
- The main features of this paraneoplasia is the presence of symmetrical papulosquamous eruptions (psoriasiform cutaneous eruptions), nail dystrophy and skin scaling usually localized in the body extremities (acral distribution) which may affect ears, nose, cheeks, hands, feet, fingers, toes, elbows and knees.
- Less frequently, skin bullae and vesicles as well as mucosa alterations can occur concomitantly to the more typical cutaneous lesions.
Laboratory Findings
- Any clinical sign that could suggest Bazex syndrome should automatically guide a cutaneous biopsy.
- Skin biopsies generally provide a mixture of findings that may be found in several more common disorders like hyperkeratosis, acanthosis, spongiosis, mononuclear perivascular infiltrate, dyskeratotic keratinocytes and vacuolar degeneration of keratinocytes.
Other Diagnostic Tests
- A complete screening of the upper aerodigestive tract should be done.
- If no tumour is found in the head and neck region, further investigation of other possible affected primary sites or metastasis should be performed, such as mediastinum, colon, bladder, prostate, uterus and vulva.
- Rarely direct immunofluorescence has been positive in patients with Bazex syndrome.[2]
Treatment
- The definitive therapy is the treatment of the underlying tumour.
- Skin lesions associated with Bazex syndrome seems to be resistant to several therapeutical modalities such as keratolytics, steroids and antibiotics and the nail changes are usually persistent.
References
- ↑ Freedberg, et al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). McGraw-Hill. ISBN 0-07-138076-0.
- ↑ 2.0 2.1 Pecora, A. L. (1983). "Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature". Archives of Dermatology. 119 (10): 820–826. doi:10.1001/archderm.119.10.820. ISSN 0003-987X.
- ↑ Lucker, G.P.H.; Steijlen, P.M. (1995). "Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin's disease". British Journal of Dermatology. 133 (2): 322–325. doi:10.1111/j.1365-2133.1995.tb02641.x. ISSN 0007-0963.
- ↑ Sarkar, B.; Knecht, R.; Sarkar, C.; Weidauer, H. (1998). "Bazex syndrome (acrokeratosis paraneoplastica)". European Archives of Oto-Rhino Laryngology. 255 (4): 205–210. doi:10.1007/s004050050044. ISSN 0937-4477.
- ↑ Jacobsen, F. K. (1984). "Acrokeratosis paraneoplastica (Bazex' syndrome)". Archives of Dermatology. 120 (4): 502–504. doi:10.1001/archderm.120.4.502. ISSN 0003-987X.
- ↑ Poligone, Brian; Christensen, Sean R; Lazova, Rossitza; Heald, Peter W (2007). "Bazex syndrome (acrokeratosis paraneoplastica)". The Lancet. 369 (9560): 530. doi:10.1016/S0140-6736(07)60240-2. ISSN 0140-6736.
- ↑ 7.0 7.1 Moore, Rachael L.; Devere, Theresa S. (2008). "Epidermal Manifestations of Internal Malignancy". Dermatologic Clinics. 26 (1): 17–29. doi:10.1016/j.det.2007.08.008. ISSN 0733-8635.
- ↑ Chave, T. A.; Bamford, W. M.; Harman, K.E. (2004). "Acrokeratosis paraneoplastica associated with recurrent metastatic thymic carcinoma". Clinical and Experimental Dermatology. 29 (4): 430–432. doi:10.1111/j.1365-2230.2004.01539.x. ISSN 0307-6938.
- ↑ Sator, Paul-Gunther; Breier, Friedrich; Gschnait, Friedrich (2006). "Acrokeratosis paraneoplastica (Bazex's syndrome): Association with liposarcoma". Journal of the American Academy of Dermatology. 55 (6): 1103–1105. doi:10.1016/j.jaad.2006.05.064. ISSN 0190-9622.